Literature DB >> 10452276

Markers of endothelial cell activation and injury in childhood haemolytic uraemic syndrome.

C H Nevard1, A D Blann, K M Jurd, G B Haycock, B J Hunt.   

Abstract

Diarrhoea-associated haemolytic uraemic syndrome (D+ HUS) is usually caused by verotoxin-producing Escherichia coli. Histology shows endothelial swelling with localised thrombus. Activation of coagulation and fibrinolysis also occurs. These facts, combined with the knowledge that recovery usually follows within weeks, led us to hypothesise that verotoxin causes localised endothelial cell activation but not injury. Markers of endothelial cell activation and injury were measured serially in 30 children with acute D+ HUS, healthy children, and children receiving chronic dialysis. Interpretation of markers was complicated by the renal dysfunction characteristic of D+ HUS. Nevertheless there was no evidence for endothelial cell injury, as soluble tissue factor levels were not increased and soluble thrombomodulin levels were lower than dialysed controls (P<0.001). In the acute phase, soluble vascular cell adhesion molecule levels were raised above normal (P<0.001), but were lower than dialysed controls (P<0.001), and soluble E-selectin levels were not significantly increased compared with normal controls (P=0.2). Hence, there was no evidence for endothelial cell damage or endothelial cell activation by the time children reached hospital; but this study did not exclude the possibility that endothelial cell activation occurred prior to hospital admission.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452276     DOI: 10.1007/s004670050644

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  8 in total

Review 1.  Shiga toxin pathogenesis: kidney complications and renal failure.

Authors:  Tom G Obrig; Diana Karpman
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

Review 2.  Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): the new thinking.

Authors:  J Liu; M Hutzler; C Li; L Pechet
Journal:  J Thromb Thrombolysis       Date:  2001-05       Impact factor: 2.300

Review 3.  Circulating Thrombomodulin: Release Mechanisms, Measurements, and Levels in Diseases and Medical Procedures.

Authors:  Mallorie Boron; Tiffany Hauzer-Martin; Joseph Keil; Xue-Long Sun
Journal:  TH Open       Date:  2022-07-11

4.  Vascular dysfunction in a murine model of severe hemolysis.

Authors:  Anne C Frei; YiHe Guo; Deron W Jones; Kirkwood A Pritchard; Karen A Fagan; Neil Hogg; Nancy J Wandersee
Journal:  Blood       Date:  2008-05-13       Impact factor: 22.113

5.  Role of the renin angiotensin system in TNF-alpha and Shiga-toxin-induced tissue factor expression.

Authors:  Eirini Nestoridi; Rafail I Kushak; Olga Tsukurov; Eric F Grabowski; Julie R Ingelfinger
Journal:  Pediatr Nephrol       Date:  2007-11-30       Impact factor: 3.714

6.  Decrease of thrombomodulin contributes to the procoagulant state of endothelium in hemolytic uremic syndrome.

Authors:  Gabriela C Fernández; Maroeska W M Te Loo; Thea J A van der Velden; Lambert P W van der Heuvel; Marina S Palermo; Leo L A Monnens
Journal:  Pediatr Nephrol       Date:  2003-08-12       Impact factor: 3.714

Review 7.  Current evidence for the role of complement in the pathogenesis of Shiga toxin haemolytic uraemic syndrome.

Authors:  Lindsay S Keir; Moin A Saleem
Journal:  Pediatr Nephrol       Date:  2013-07-11       Impact factor: 3.714

Review 8.  Biomarkers of endothelial activation/dysfunction in infectious diseases.

Authors:  Andrea V Page; W Conrad Liles
Journal:  Virulence       Date:  2013-04-19       Impact factor: 5.882

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.